[The research progress about Wnt pathway of lung cancer stem cells]

Xiaojiang Li1, Yingjie Jia, Wenzhi Zhang

  • 1Department of Oncology, the First Teaching Hospital, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Insights

Targeting the Wnt/β-catenin pathway can inhibit lung cancer stem cell proliferation. This research explores the Wnt pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Context:

  • Lung cancer stem cells (LCSCs) are crucial for tumor growth and recurrence.
  • The Wnt/β-catenin signaling pathway is a key regulator of LCSCs.
  • Understanding this pathway's role is vital for developing new lung cancer therapies.

Purpose:

  • To investigate the relationship between the Wnt pathway and lung cancer stem cells.
  • To review state-of-the-art research from 2005-2010 on LCSCs and Wnt signaling.
  • To identify therapeutic strategies targeting this pathway.

Summary:

  • The Wnt/β-catenin pathway is essential for lung cancer stem cell proliferation and self-renewal.
  • Inhibiting the Wnt pathway or its key proteins can restrain LCSC growth.
  • This provides a novel therapeutic approach for lung cancer treatment.

Impact:

  • Highlights the Wnt/β-catenin pathway as a potential therapeutic target for lung cancer.
  • Suggests that modulating this pathway could offer new treatment strategies.
  • Emphasizes the importance of LCSCs in lung cancer and the need for targeted therapies.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...